97-28598. Centers for Disease Control and Prevention; Statement of Organization, Functions, and Delegations of Authority  

  • [Federal Register Volume 62, Number 209 (Wednesday, October 29, 1997)]
    [Notices]
    [Page 56197]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-28598]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Public Health Service
    
    
    Centers for Disease Control and Prevention; Statement of 
    Organization, Functions, and Delegations of Authority
    
        Part C (Centers for Disease Control and Prevention) of the 
    Statement of Organization, Functions, and Delegations of Authority of 
    the Department of Health and Human Services (45 FR 67772-76, dated 
    October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
    amended most recently at 62 FR 51474 and 51479, dated October 1, 1997) 
    is amended to reflect organizational changes within the National Center 
    for Infectious Diseases (NCID), Centers for Disease Control and 
    Prevention.
        Section C-B, Organization and Functions, is hereby amended as 
    follows:
        Delete the functional statement for the Scientific Resources 
    Program (CRL) and insert the following:
        (1) Provides animals, animal blood products, glassware, mammalian 
    tissue cultures, microbiological media, special reagents, and other 
    laboratory materials in support of research and service activities to 
    NCID laboratories and other CDC organizations; (2) installs, 
    fabricates, modifies, services, and maintains laboratory equipment used 
    in the research and service activities of CDC; (3) develops and 
    implements applied research programs to expand and enhance the use of 
    animal models necessary to support research and diagnostic programs and 
    to improve breeding and husbandry procedures; (4) conducts both basic 
    and applied research in cell biology and in the expansion of tissue 
    culture technology as a research and diagnostic tool for infectious 
    disease activities; (5) provides services for NCID investigators in 
    protein and DNA synthesis and sequencing; (6) maintains a bank of serum 
    specimens of epidemiological and special significance to CDC's research 
    and diagnostic activities; (7) obtains and distributes experimental 
    vaccines and drugs, antisera and antitoxins, and immune globulins; (8) 
    for reagents prepared at CDC, maintains a computerized inventory; 
    provides dispensing, lyophilization, capping, and labeling; and 
    retrieves from storage and ships to requesters; (9) provides support 
    for liquid nitrogen freezers; (10) maintains an international 
    hemoglobinometry reference laboratory; (11) produces, maintains, and 
    distributes national and international hemoglobin reference standard 
    preparations; (12) administratively and technically supports the CDC 
    Animal Policy Board and the Atlanta Area Animal Care and Use Committee; 
    (13) provides computer support services for the Program's activities.
        Delete the title and functional statement for the Molecular 
    Pathology and Ultrastructure Activity (CRUE) and insert the following:
    
    Infectious Disease Pathology Activity (CRUE)
    
        (1) Serves as a scientific and technical resource to NCID by 
    providing expertise in molecular pathology, histopathology, and 
    ultrastructural analysis for detecting infectious disease agents and 
    studying the interactions between microbial agents and host cells; (2) 
    develops, improves, evaluates, and applies special ultrastructural, 
    immunohistologic, and/or nucleic acid probe technologies for detecting 
    microbial agents and/or expressed gene products in tissue specimens or 
    tissue culture; (3) conducts basic and applied research into the 
    pathogenesis of infectious diseases; (4) provides intramural and 
    extramural technical and professional expertise for assistance in 
    training in infectious disease pathology and molecular approaches to 
    the identification of specific nucleic acid sequences and specific 
    antigens in tissue specimens; (5) provides for tracking, distribution, 
    and testing of reference /diagnostic pathology specimens submitted 
    through the data and special handling system; (6) provides molecular 
    pathology, histopathology, and ultrastructure reference/diagnostic 
    support and epidemic aid to state and local health departments, other 
    federal agencies, and national and international health organizations.
    
        Dated: October 16, 1997.
    David Satcher,
    Director.
    [FR Doc. 97-28598 Filed 10-28-97; 8:45 am]
    BILLING CODE 4160-18-M
    
    
    

Document Information

Published:
10/29/1997
Department:
Public Health Service
Entry Type:
Notice
Document Number:
97-28598
Pages:
56197-56197 (1 pages)
PDF File:
97-28598.pdf